Drug Profile
Icopezil
Alternative Names: CP 118954Latest Information Update: 05 Sep 2000
Price :
$50
*
At a glance
- Originator Pfizer
- Class Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 05 Sep 2000 Discontinued-phase II in Alzheimer's disease in Japan (Unknown route)
- 05 Sep 2000 Discontinued-phase II in Alzheimer's disease in USA (Unknown route)
- 23 Nov 1999 No-Development-Reported for Alzheimer's disease in Japan (Unknown route)